Incannex Healthcare Ltd
NASDAQ:IXHL

Watchlist Manager
Incannex Healthcare Ltd Logo
Incannex Healthcare Ltd
NASDAQ:IXHL
Watchlist
Price: 0.344 USD -4.02% Market Closed
Market Cap: $119.1m

Operating Margin

-1 451.3%
Current
Improving
by 72%
vs 3-y average of -1 523.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 451.3%
=
Operating Income
AU$-20m
/
Revenue
AU$1.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 451.3%
=
Operating Income
$-20m
/
Revenue
AU$1.4m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Incannex Healthcare Ltd
ASX:IHL
43.3m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.5B EUR
Loading...

Market Distribution

Lower than 78% of companies in Australia
Percentile
22st
Based on 3 951 companies
22st percentile
-1 451.3%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Incannex Healthcare Ltd
Glance View

Market Cap
119.1m USD
Industry
Pharmaceuticals

Incannex Healthcare Ltd. is a cannabinoid and psychedelic compound medicine development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The company is a clinical stage pharmaceutical development company. The firm is engaged in developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies. Its product candidate IHL-42X is developing a combination of acetazolamide and dronabinol to reduce the apnea hypopnea index (AHI), IHL-216A is a combination of isoflurane and CBD to prevent development of traumatic brain injury (TBI)/concussion, HL-675A comprises a combination of hydroxychloroquine and CBD in prevention and treatment of inflammatory lung conditions (ARDS, COPD, asthma, and bronchitis), rheumatoid arthritis and inflammatory bowel diseases and Psi-GAD is providing Psychedelic-assisted psychotherapy for Generalized Anxiety Disorder (GAD).

IXHL Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 451.3%
=
Operating Income
AU$-20m
/
Revenue
AU$1.4m
What is Incannex Healthcare Ltd's current Operating Margin?

The current Operating Margin for Incannex Healthcare Ltd is -1 451.3%, which is above its 3-year median of -1 523.3%.

How has Operating Margin changed over time?

Over the last 3 years, Incannex Healthcare Ltd’s Operating Margin has decreased from -478% to -1 451.3%. During this period, it reached a low of -1 889.7% on Jun 30, 2022 and a high of -377.8% on Dec 31, 2020.

Back to Top